Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
169,115
-
Share change
-
+169,115
-
Total reported value
-
$1,318,890
-
Price per share
-
$7.90
-
Number of holders
-
10
-
Value change
-
+$1,318,890
-
Number of buys
-
10
Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q4 2022
As of 31 Dec 2022,
Hoth Therapeutics, Inc. - COM NEW (HOTH) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
169,115 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC, UBS Group AG, Tower Research Capital LLC (TRC), Royal Bank of Canada, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BlackRock Inc., and FMR LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.